271 related articles for article (PubMed ID: 26825839)
21. The prognostic value of histologic subtype in node-positive early-stage cervical cancer after hysterectomy and adjuvant radiotherapy.
Zhou J; Zhang WW; Wu SG; He ZY; Sun JY; Yang GF; Li FY
Int J Surg; 2017 Aug; 44():1-6. PubMed ID: 28583891
[TBL] [Abstract][Full Text] [Related]
22. Definitive local therapy is associated with improved overall survival in metastatic cervical cancer.
Venigalla S; Guttmann DM; Horne ZD; Carmona R; Shabason JE; Beriwal S
Pract Radiat Oncol; 2018; 8(6):e377-e385. PubMed ID: 30174248
[TBL] [Abstract][Full Text] [Related]
23. The Treatment of Pelvic Locoregional Recurrence of Cervical Cancer After Radical Surgery With Intensity-Modulated Radiation Therapy Compared With Conventional Radiotherapy: A Retrospective Study.
Yin YJ; Li HQ; Sheng XG; Du XL; Wang C; Lu CH; Pan CX
Int J Gynecol Cancer; 2015 Jul; 25(6):1058-65. PubMed ID: 25647254
[TBL] [Abstract][Full Text] [Related]
24. Concurrent chemoradiotherapy incorporating high-dose rate brachytherapy for locally advanced cervical carcinoma: survival outcomes, patterns of failure, and prognostic factors.
Teh J; Yap SP; Tham I; Sethi VK; Chua EJ; Yeo R; Ho TH; Tay EH; Chia YN; Soh LT; Khoo-Tan HS
Int J Gynecol Cancer; 2010 Apr; 20(3):428-33. PubMed ID: 20375809
[TBL] [Abstract][Full Text] [Related]
25. Prognostic Factors and Treatment Outcome for Patients with Stage IVB Cervical Cancer.
Oishi S; Kudaka W; Toita T; Ariga T; Nakamoto T; Wakayama A; Nagai Y; Kaneshima I; Nishihira K; Aoki Y
Anticancer Res; 2016 Jul; 36(7):3471-5. PubMed ID: 27354610
[TBL] [Abstract][Full Text] [Related]
26. A retrospective review of patients with stage IB2 cervical cancer treated with radical radiation versus radical surgery as a primary modality.
Alleyne-Mike K; van Wijk L; Hunter A
Int J Gynecol Cancer; 2013 Sep; 23(7):1287-94. PubMed ID: 23863456
[TBL] [Abstract][Full Text] [Related]
27. Patterns of spread in node-positive cervical cancer: the relationship between local control and distant metastases.
Stock RG; Chen AS; Karasek K
Cancer J Sci Am; 1996; 2(5):256-62. PubMed ID: 9166542
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathological factors influencing the prognosis of cervical cancer.
Gai J; Wang X; Meng Y; Xu Z; Kou M; Liu Y
J BUON; 2019; 24(1):291-295. PubMed ID: 30941983
[TBL] [Abstract][Full Text] [Related]
29. Survival after curative pelvic exenteration for primary or recurrent cervical cancer: a retrospective multicentric study of 167 patients.
Chiantera V; Rossi M; De Iaco P; Koehler C; Marnitz S; Ferrandina G; Legge F; Parazzini F; Scambia G; Schneider A; Vercellino GF
Int J Gynecol Cancer; 2014 Jun; 24(5):916-22. PubMed ID: 24442006
[TBL] [Abstract][Full Text] [Related]
30. Indicators of survival and prognostic factors in women treated for cervical cancer at a tertiary care center in Saudi Arabia.
Anfinan N; Sait K
Ann Saudi Med; 2020; 40(1):25-35. PubMed ID: 32026705
[TBL] [Abstract][Full Text] [Related]
31. Significance of the absolute number and ratio of metastatic lymph nodes in predicting postoperative survival for the International Federation of Gynecology and Obstetrics stage IA2 to IIA cervical cancer.
Chen Y; Zhang L; Tian J; Fu X; Ren X; Hao Q
Int J Gynecol Cancer; 2013 Jan; 23(1):157-63. PubMed ID: 23221732
[TBL] [Abstract][Full Text] [Related]
32. Aberrant expression of microRNA-26b and its prognostic potential in human cervical cancer.
Luo M; Shen D; Wang W; Xian J
Int J Clin Exp Pathol; 2015; 8(5):5542-8. PubMed ID: 26191262
[TBL] [Abstract][Full Text] [Related]
33. Stage IIB-IVB cervical adenocarcinoma: prognostic factors and survival.
Lea JS; Sheets EE; Wenham RM; Duska LR; Coleman RL; Miller DS; Schorge JO
Gynecol Oncol; 2002 Jan; 84(1):115-9. PubMed ID: 11748986
[TBL] [Abstract][Full Text] [Related]
34. Prognostic model in patients with early-stage squamous cell carcinoma of the uterine cervix: a combination of invasive margin pathological characteristics and lymphovascular space invasion.
Khunamornpong S; Lekawanvijit S; Settakorn J; Sukpan K; Suprasert P; Siriaunkgul S
Asian Pac J Cancer Prev; 2013; 14(11):6935-40. PubMed ID: 24377504
[TBL] [Abstract][Full Text] [Related]
35. Post-recurrence survival in patients with cervical cancer.
Cibula D; Dostálek L; Jarkovsky J; Mom CH; Lopez A; Falconer H; Scambia G; Ayhan A; Kim SH; Isla Ortiz D; Klat J; Obermair A; Di Martino G; Pareja R; Manchanda R; Kosťun J; Dos Reis R; Meydanli MM; Odetto D; Laky R; Zapardiel I; Weinberger V; Benešová K; Borčinová M; Cardenas F; Wallin E; Pedone Anchora L; Akilli H; Abu-Rustum NR; Barquet-Muñoz SA; Javůrková V; Fischerová D; van Lonkhuijzen LRCW
Gynecol Oncol; 2022 Feb; 164(2):362-369. PubMed ID: 34955236
[TBL] [Abstract][Full Text] [Related]
36. High tumor interstitial fluid pressure identifies cervical cancer patients with improved survival from radiotherapy plus cisplatin versus radiotherapy alone.
Milosevic MF; Pintilie M; Hedley DW; Bristow RG; Wouters BG; Oza AM; Laframboise S; Hill RP; Fyles AW
Int J Cancer; 2014 Oct; 135(7):1692-9. PubMed ID: 23904154
[TBL] [Abstract][Full Text] [Related]
37. Prognostic factors and adjuvant therapy on survival in early-stage cervical adenocarcinoma/adenosquamous carcinoma after primary radical surgery: A Taiwanese Gynecologic Oncology Group (TGOG) study.
Twu NF; Ou YC; Liao CI; Chang WY; Yang LY; Tang YH; Chen TC; Chen CH; Chen TH; Yeh LS; Hsu ST; Chen YC; Chang CC; Cheng YM; Huang CY; Liu FS; Lin YS; Hsiao SM; Kan YY; Lai CH
Surg Oncol; 2016 Sep; 25(3):229-35. PubMed ID: 27566027
[TBL] [Abstract][Full Text] [Related]
38. Isolated pulmonary metastases in patients with cervical cancer and the factors affecting survival after recurrence.
Gülseren V; Kocaer M; Güngördük Ö; Özdemir İA; Gölbaşı C; Budak A; Gökçü M; Sancı M; Güngördük K
Ginekol Pol; 2018; 89(11):593-598. PubMed ID: 30508210
[TBL] [Abstract][Full Text] [Related]
39. Pathological Risk Factors and Outcomes in Women With Stage IB2 Cervical Cancer Treated With Primary Radical Surgery Versus Chemoradiotherapy.
Bradbury M; Founta C; Taylor W; Kucukmetin A; Naik R; Ang C
Int J Gynecol Cancer; 2015 Oct; 25(8):1476-83. PubMed ID: 26244756
[TBL] [Abstract][Full Text] [Related]
40. Effects of Neoadjuvant Chemotherapy Plus Radical Surgery as Front Line Treatment Strategy in Patients Affected by FIGO Stage III Cervical Cancer.
Di Donato V; Schiavi MC; Ruscito I; Visentin VS; Palaia I; Marchetti C; Fischetti M; Monti M; Muzii L; Benedetti Panici P
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):841-849. PubMed ID: 27678502
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
